NCT02343614View on ClinicalTrials.gov

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions
Non Muscle Invasive Bladder Cancer
Interventions
DRUG

Celecoxib

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

OTHER

NCT02343614 - Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter